Skip to main content
All lobbying filings

I STREET ADVOCATES

Lobbying for CHILDREN'S CAUSE FOR CANCER · The Childrens Cause for Cancer Advocacy (CCCA) is an advocacy organization working to ach

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 6, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act

 Bills named in this filing 3
  • S. 705
    Innovation in Pediatric Drugs Act of 2025
  • H.R. 8839
    Lainie Jones Comprehensive Cancer Survivorship Act of 2026
  • S. 4717
    Asal Sayas National Strategy on Young Adult Cancers Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem